Elbit Imaging Announces Completion of the Sale of Suwalki Plaza Shopping and Entertainment Center in Poland, by Its Subsidiar...
February 01 2017 - 9:10AM
Elbit Imaging Ltd. (“EI” or the
“Company”) (TASE:EMITF), (NASDAQ:EMITF) announced
today, in further to the announcement, dated December 22, 2016,
that
Plaza Centers N.V. ("Plaza") (LSE:PLAZ), an
indirect subsidiary of the Company, has completed the sale of
Suwałki Plaza shopping and entertainment center in Poland to an
investment fund for Euro 42.3 million, which is in line with
Plaza’s last reported book value.
Having completed the transaction, Plaza has
received approximately Euro 16 million net cash, after the
repayment of the bank loan (approximately Euro 26.6 million), and
other working capital adjustments.
Suwałki Plaza, with its 20,000 sqm GLA, is the
only shopping center in Suwałki, a Polish city with population of
approximately 75,000, close to the border with Lithuania. It is
located next to a major road which connects the Baltic countries to
Poland and has a potential catchment area of 200,000 inhabitants.
The center is fully let.
Out of the net proceeds, at least 75% will be
distributed to Plaza’s bondholders by or before March 31, 2017, in
line with Plaza’s stated amended restructuring Plan.
About Elbit Imaging Ltd.
Elbit Imaging Ltd. operates in the following
principal fields of business: (i) Commercial centers - initiation,
construction, and sale of commercial centers and other mixed-use
property projects, predominantly in the retail sector, located in
Central and Eastern Europe. In certain circumstances and depending
on market conditions, the Group operates and manages commercial
centers prior to their sale. (ii) Hotel - operation and
management of the Radisson hotel complex in Bucharest, Romania.
(iii) Medical industries and devices - (a) research and
development, production and marketing of magnetic resonance imaging
guided focused ultrasound treatment equipment, and (b) development
of stem cell population expansion technologies and stem cell
therapy products for transplantation and regenerative medicine.
(iv) Plots in India - plots designated for sale initially
designated to residential projects.
Any forward-looking statements in our releases
include statements regarding the intent, belief or current
expectations of Elbit Imaging Ltd. and our management about our
business, financial condition, results of operations, and its
relationship with its employees and the condition of our
properties. Words such as “believe,” “expect,” “intend,” “estimate”
and similar expressions are intended to identify forward-looking
statements but are not the exclusive means of identifying such
statements. Actual results may differ materially from those
projected, expressed or implied in the forward-looking statements
as a result of various factors including, without limitation, a
change in market conditions, a decision to deploy the cash for
other business opportunities and the factors set forth in our
filings with the Securities and Exchange Commission including,
without limitation, Item 3.D of our annual report on Form 20-F for
the fiscal year ended December 31, 2015, under the caption “Risk
Factors.” Any forward-looking statements contained in our releases
speak only as of the date of such release, and we caution existing
and prospective investors not to place undue reliance on such
statements. Such forward-looking statements do not purport to be
predictions of future events or circumstances, and therefore, there
can be no assurance that any forward-looking statement contained in
our releases will prove to be accurate. We undertake no obligation
to update or revise any forward-looking statements.
For Further Information:
Company Contact
Ron Hadassi
Chairman of the Board of Directors
Tel: +972-3-608-6048
Fax: +972-3-608-6050
ron@elbitimaging.com
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Elbit Imaging (CE) (USOTC:EMITF)
Historical Stock Chart
From Apr 2023 to Apr 2024